Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer’s Disease: The Role of Protein-Protein Interactions in Current and Future Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|14|2015-2034

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 2015-2034

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein-Protein Interactions at the Adrenergic Receptors

By  

Current Drug Targets, Vol. 13, Iss. 1, 2012-01 ,pp. : 15-27

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-protein interactions at G-protein-coupled receptors

By Milligan G.   White J.H.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 10, 2001-10 ,pp. : 513-518

Elsevier

Access to resources Recommend Favorite

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

By Maelicke A.   Albuquerque E.X.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 165-170

Elsevier

Access to resources Recommend Favorite

Pharmacological Interference With Protein-protein Interactions of Akinase Anchoring Proteins as a Strategy for the Treatment of Disease

By  

Current Drug Targets, Vol. 17, Iss. 10, 2016-08 ,pp. : 1147-1171

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of 7 Nicotinic Acetylcholine Receptors and 7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2035-2049

Bentham Science Publishers

Access to resources Recommend Favorite